Cypress Capital Group Perkinelmer Inc Transaction History

Cypress Capital Group

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$119.0 - $147.98 $285,957 - $355,595	2,403 New	2,403 $336,000
Q1 2022 May 16, 2022	BUY	$162.31 - $192.2 $39,279 - $46,512	242 Added 18.1%	1,579 $268,000
Q4 2021 Feb 15, 2022	SELL	$166.66 - $201.06 $8,333 - $10,053	-50 Reduced 3.6%	1,337 $269,000
Q3 2021 Oct 12, 2021	BUY	$151.98 - $190.5 $210,796 - $264,223	1,387 New	1,387 $240,000

576

108M

57.1K

23.1K

Ticker PKI
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 126,224,000
Market Cap $15.3B
Description
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detectio...

Get notified when there are updates to the investment portfolio of Cypress Capital Group, based on Form 13F filings with the SEC.

Stay updated on Cypress Capital Group with notifications on news.